BlackRock, Inc. 13D and 13G filings for Sigilon Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-07-08 4:56 pm Sale |
2022-06-30 | 13G | Sigilon Therapeutics, Inc. SGTX |
BlackRock Inc. BLK |
82,007 3.300% |
-51,574 (-38.61%) |
Filing |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | Sigilon Therapeutics, Inc. SGTX |
BlackRock Inc. BLK |
133,581 5.400% |
133,581 (New Position) |
Filing |